Gore Prevails in Heart Device Patent Infringement Suit
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
Unique biomaterial for hernia repair implanted for the first time in Gore’s Clinical Quality Improvement project
Presentations and Discussions from the Surgical Bypass Summit Available at www.surgicalbypass.com
Results of early cannulation clinical trial presented at the 2013 VEITHsymposium
Two-year study demonstrates improved patient satisfaction with Gore material
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration
Gore has appeared in every edition of the rankings, published annually in Fortune magazine. The company is among just 12 “Great Place to Work Legends” to hold this distinction.
New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure